Who owns NERVGEN PHARMA CORP.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NGEN from SEC Form 13F filings across 62 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 62 institutions disclosed 12.3M shares of NERVGEN PHARMA CORP. worth $24.9M — about 13.3% of shares outstanding; the largest disclosed holder is Empery Asset Management, LP. Source: SEC Form 13F filings, parsed by EvidInvest.
62
13F holders
$24.9M
value, 2026 filers
13.3%
of shares outstanding (12.3M sh)
22
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NGEN's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Empery Asset Management, LPNEW | 4.0M | $8.2M | 9.5% | 4.3% | new |
| 2 | Rock Springs Capital Management LPNEW | 1.2M | $2.5M | 0.1% | 1.3% | new |
| 3 | DAFNA Capital Management LLCNEW | 1.1M | $2.2M | 0.4% | 1.1% | new |
| 4 | Ghisallo Capital Management LLCNEW | 1.0M | $2.1M | 0.0% | 1.1% | new |
| 5 | ARMISTICE CAPITAL, LLCNEW | 678,000 | $1.4M | 0.0% | 0.7% | new |
| 6 | LMR Partners LLPNEW | 600,000 | $1.2M | 0.0% | 0.6% | new |
| 7 | Stonepine Capital Management, LLCNEW | 571,678 | $740,220 | 0.3% | 0.6% | new |
| 8 | MARSHALL WACE, LLP | 435,962 | $898,081 | 0.0% | 0.5% | +117.6% |
| 9 | UBS Group AG | 379,726 | $782,236 | 0.0% | 0.4% | +517.3% |
| 10 | JANE STREET GROUP, LLCNEW | 270,750 | $557,746 | 0.0% | 0.3% | new |
| 11 | Woodline Partners LPNEW | 250,500 | $516,030 | 0.0% | 0.3% | new |
| 12 | PFG Investments, LLC | 217,500 | $448,050 | 0.0% | 0.2% | +8.2% |
| 13 | BANK OF AMERICA CORP /DE/ | 186,200 | $383,572 | 0.0% | 0.2% | -7.2% |
| 14 | ROYAL BANK OF CANADA | 176,075 | $363,000 | 0.0% | 0.2% | +2.4% |
| 15 | Quadrature Capital LtdNEW | 134,518 | $277,107 | 0.0% | 0.1% | new |
| 16 | BANK OF MONTREAL /CAN/ | 78,394 | $284,382 | 0.0% | 0.1% | +24.6% |
| 17 | Integrated Wealth Concepts LLC | 74,215 | $152,883 | 0.0% | 0.1% | -14.5% |
| 18 | CAPTRUST FINANCIAL ADVISORS | 64,423 | $132,711 | 0.0% | 0.1% | +3.3% |
| 19 | GEODE CAPITAL MANAGEMENT, LLCNEW | 58,040 | $119,562 | 0.0% | 0.1% | new |
| 20 | OSAIC HOLDINGS, INC. | 51,093 | $105,250 | 0.0% | 0.1% | +27.8% |
| 21 | HRT FINANCIAL LP | 43,858 | $90 | 0.0% | 0% | +105.3% |
| 22 | AXQ CAPITAL, LPNEW | 43,099 | $88,784 | 0.0% | 0% | new |
| 23 | MILLENNIUM MANAGEMENT LLCNEW | 39,740 | $81,864 | 0.0% | 0% | new |
| 24 | GREAT VALLEY ADVISOR GROUP, INC. | 35,500 | $73,130 | 0.0% | 0% | +69.0% |
| 25 | Virtu Financial LLCNEW | 34,589 | $71 | 0.0% | 0% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.